CAMBRIDGE, MA, USA & BRISBANE, Australia I2, 2025 I Vaxxas, a clinical-stage biotechnology company commercializing a novel high-density ...
This comes after the Maine CDC suspended and later revoked HEAL's syringe exchange certification for all sites in Bangor, ...
Global Needle-Free Injectors Industry to Reach USD 42.79 Billion by 2032, Growing at 12% Annual Rate
The needle-free injectors market is projected to grow at 12% annually, reaching USD 42.79 billion by 2032. Increasing ...
Becton, Dickinson and Co. (BD) is investing in its U.S. manufacturing network to add capacity for critical medical devices, ...
Clinical-stage Australian biotechnology company Vaxxas will receive $3.2 million from the US Biomedical Advanced Research and ...
Version Report "Disposable Syringes Market Size, Statistics, Growth Trend Analysis, and Forecast Report, 2025 – 2034" ...
day-old baby endures 24 days of pain after needle found in leg post vaccination, sparking negligence accusations at hospital.
A vein finding machine, advice on needle use and aftercare consultation: How exactly Dublin’s first injection centre in Merchant’s Quay works.
BD invested $10 million last year to increase manufacturing capacity. The recent expansion has created more than 200 jobs.
Needle-free injections directly target vaccine hesitancy by removing one of its primary psychological barriers—needle-induced ...
Denver Mayor Mike Johnston vetoes council bill removing needle exchange program cap and distance requirements.
BD (NYSE: BDX) announced today that it plans to invest further in U.S. manufacturing to add capacity for certain critical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback